Table 1.

Parameters in control and omarigliptin group with NAFLD at baseline and 12 months

Time (month)	Control (n = 12)		Omarigliptin (n = 21)
	0	12	0	12
HbA1c	6.83 ± 0.69	6.80 ± 0.63	6.91 ± 0.73	6.80 ± 0.71
BMI	26.5 ± 2.4	26.7 ± 2.1	26.6 ± 2.7	26.5 ± 2.7
ALT	30.8 ± 19.5	32.4 ± 28.4	30.1 ± 20.5	25.2 ± 14.4 *
AST	35.1 ± 8.4	37.5 ± 10.0	34.8 ± 11.6	30.0 ± 8.6 *
γGTP	38.5 ± 6.6	39.0 ± 5.5	43.8 ± 29.6	32.7 ± 19.8 *
hsCRP	0.130 ± 0.04	0.151 ± 0.06	0.105 ± 0.05	0.042 ± 0.02 **
HOMA-IR	2.83 ± 0.79	2.72 ± 0.82	2.75 ± 1.28	1.85 ± 0.88 **

Data were expressed as mean ± standard deviation. (*p < 0.05, **p < 0.01)